Reacción #1441

ord-52eeeb285aa44f2a8df38cb2bd9296be

Ecuación de reacción

CC(C)(C)OC(=O)NCC(=O)O
t-butoxycarbonylglycine
On1nnc2ccccc21
1-hydroxybenztriazole
CN1CCOCC1
N-methylmorpholine
CCN=C=NCCCN(C)C.Cl
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride
Br.Nc1nc2c(s1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2
4'-[(2-amino-5,6-dihydro-4H-thiazolo[5,4-d][1]benzazepin-6-yl)carbonyl]-2-phenylbenzanilide hydrobromide
CC(C)O.Cl.NCC(=O)Nc1nc2c(s1)CCN(C(=O)c1ccc(NC(=O)c3ccccc3-c3ccccc3)cc1)c1ccccc1-2
4'-[(2-glycylamino-5,6-dihydro-4H-thiazolo[5,4-d][1]benzazepin-6-yl)carbonyl]-2-phenylbenzanilide 2-propylalcohol hydrochloride
Rendimiento 55.7%

Condiciones de reacción

Condiciones detalladas
See reaction.notes.procedure_details.

Tratamiento posterior

  1. 1
    workup.ADDITIONwas added to the resulting solution
  2. 2
    workup.STIRRINGstirred for 60 minutes
  3. 3
    TemperaturaTo this reaction solution, again cooled on an ice bath
  4. 4
    workup.DISSOLUTIONhad been dissolved
  5. 5
    workup.STIRRINGstirring at room temperature
  6. 6
    workup.STIRRINGstirred for 60 minutes
  7. 7
    Otrosubjected to phase separation
  8. 8
    OtroThe dichloromethane layer was separated
  9. 9
    Lavadowashed with a saturated sodium bicarbonate aqueous solution
  10. 10
    Secadoa saturated sodium chloride aqueous solution once for each and then dried over anhydrous magnesium sulfate
  11. 11
    OtroAfter removing the solvent
  12. 12
    workup.DISTILLATIONby distillation
  13. 13
    TemperaturaWith cooling on an ice bath
  14. 14
    workup.ADDITIONthe suspension was mixed with 4.4 ml of 4N hydrochloric acid-dioxane
  15. 15
    workup.STIRRINGstirred for 3 hours
  16. 16
    ConcentraciónThereafter, the reaction solution was concentrated
  17. 17
    Otrothe thus obtained residue was recrystallized from 2-propyl alcohol

Procedimiento

After dissolving 176 mg of t-butoxycarbonylglycine, 205 mg of 1-hydroxybenztriazole and 0.15 ml of N-methylmorpholine in 3.5 ml of dichloromethane, 192 mg of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride was added to the resulting solution with stirring on an ice bath, and the mixture was warmed up to room temperature and stirred for 60 minutes. To this reaction solution, again cooled on an ice bath, was added dropwise 4 ml of dichloromethane in which 400 mg of the 4'-[(2-amino-5,6-dihydro-4H-thiazolo[5,4-d][1]benzazepin-6-yl)carbonyl]-2-phenylbenzanilide hydrobromide described in Example 1 and 0.103 ml of triethylamine had been dissolved, followed by overnight stirring at room temperature. The reaction solution was mixed with water, stirred for 60 minutes and then subjected to phase separation. The dichloromethane layer was separated, washed with a saturated sodium bicarbonate aqueous solution and a saturated sodium chloride aqueous solution once for each and then dried over anhydrous magnesium sulfate. After removing the solvent by distillation, the thus obtained residue was suspended in 3 ml of methyl alcohol. With cooling on an ice bath, the suspension was mixed with 4.4 ml of 4N hydrochloric acid-dioxane and stirred for 3 hours. Thereafter, the reaction solution was concentrated and the thus obtained residue was recrystallized from 2-propyl alcohol to obtain 250 mg of 4'-[(2-glycylamino-5,6-dihydro-4H-thiazolo[5,4-d][1]benzazepin-6-yl)carbonyl]-2-phenylbenzanilide 2-propylalcohol hydrochloride.

Fuente

DOI: 10.6084/m9.figshare.5104873.v1Patente: US05723606uspto-grants-1998_03